Cookson Peirce & Co’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-250,000	Closed	-$113K	–	305
2025 Q1	$113K	Buy	+250,000	New	+$113K	0.01%	264